Insulet raises 2025 revenue guidance to 19%-22% growth amid strong Omnipod adoption
Source: SeekingAlpha
2025-05-08 22:35:46 ET
More on Insulet
- Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript
- Insulet Leans Bullish (Technical Analysis)
- Insulet: Aiding Patients And Investors
- Insulet Non-GAAP EPS of $1.02 beats by $0.23, revenue of $569M beats by $25.7M
- Insulet Q1 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Insulet raises 2025 revenue guidance to 19%-22% growth amid strong Omnipod adoption
Insulet Corporation
NASDAQ: PODD
PODD Trading
-7.26% G/L:
$217.82 Last:
933,644 Volume:
$226.138 Open:
PODD Latest News
July 08, 2025 06:00:00 am
Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025
June 19, 2025 06:00:00 am
Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions
June 10, 2025 08:30:00 am
Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users
PODD Stock Data
$17,809,372,432
69,643,429
0.03%
360
N/A
Medical Equipment & Supplies
Healthcare
US
Acton
